DIRECT: A phase II/III randomized trial with dietary restriction as an adjunct to neoadjuvant chemotherapy for HER2-negative breast cancer

Author(s):
Groot, S. de; Vreeswijk, M.P.G.; Smit, V.T.H.B.M.; Heijns, J.B.; Imholz, A.L.T.; Kessels, L.W.; Jager, A.; ; Weijl, N.I.; Smorenburg, C.H.; Portielje, J.E.A.; Liefers, G.J.; Velde, C.J.H. van de; Meershoek, E.M.; Leeuwen, E. van; Fischer, M.J.; Kaptein, A.A.; Putter, H.; Longo, V.; Nortier, H.W.R.; Hoeven, K.J.M. van der; Pijl, H.; Kroep, J.R.
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-12-15
Language
English
hdl
1887/107968
doi
10.1158/0008-5472.SABCS13-OT3-1-03